Invention Grant
- Patent Title: Lung cancer diagnosis marker, antibody and application thereof
-
Application No.: US15710794Application Date: 2017-09-20
-
Publication No.: US10144771B2Publication Date: 2018-12-04
- Inventor: Chong Li
- Applicant: Chong Li
- Agency: Corridor Law Group, P.C.
- Priority: CN201510142768 20150327
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K14/705 ; G01N33/574 ; G01N33/577 ; A61K47/68 ; A61P35/00 ; C07K16/30 ; A61K49/18 ; C07K16/28 ; C07K16/44 ; C07K14/47

Abstract:
A human lung cancer marker N3G4, and use of the same as human lung cancer marker is disclosed. Hybridoma cells which produce anti-N3G4 monoclonal antibodies, and the secreted monoclonal antibody LC128, and use of LC128 for the preparation of a diagnostic agent for lung cancer are also disclosed. Kits for in vitro diagnosis comprising the monoclonal antibody LC128 and methods for detecting tumor markers in lung tissue by using the monoclonal antibody LC128 are also disclosed.
Public/Granted literature
- US20180094042A1 LUNG CANCER DIAGNOSIS MARKER, ANTIBODY AND APPLICATION THEREOF Public/Granted day:2018-04-05
Information query